EUVIMEDEUVIMED entdecken
Crossref

Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability

Natansh D Modi iD, Sandra M Swain, Marc Buyse, Nicole M Kuderer, Andrew Rowland, Frank W Rockhold, Michael J Sorich, Ashley M Hopkins

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.24.00539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Natansh D Modi und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Public Health, Flinders University, Adelaide, Australia. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Antineoplastic Agents, Drug Approval. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unlocking the full potential of clinical trials through comprehensive CSR and IPD sharing can revolutionize cancer care, enhance safety evaluations, and reduce bias in systematic reviews. It is time for all stakeholders to embrace transparency and advance patient-centered outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationAntineoplastic AgentsDrug ApprovalHumansUnited StatesNeoplasmsClinical Trials as Topic

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Georgetown Lombardi Comprehensive Cancer Center, MedStar Health, Washington, DC.
  • International Drug Development Institute (IDDI) and Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Hasselt, Belgium.
  • Advanced Cancer Research Group, Kirkland, WA.
  • Department of Biostatistics and Bioinformatics, Duke University, Durham, NC.

ORCID-Profile: Natansh D Modi

Zitieren

APA

Modi, N. D., Swain, S. M., Buyse, M., Kuderer, N. M., Rowland, A., Rockhold, F. W., Sorich, M. J., & Hopkins, A. M. (2024). Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00539

Vancouver

Modi ND, Swain SM, Buyse M, Kuderer NM, Rowland A, Rockhold FW, et al. Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00539

BibTeX
@article{Modi2024,
  author = {Modi, Natansh D and Swain, Sandra M and Buyse, Marc and Kuderer, Nicole M and Rowland, Andrew and Rockhold, Frank W and Sorich, Michael J and Hopkins, Ashley M},
  title = {Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.24.00539}
}
Kostenlos starten →